New Owner
Merck & Co., Inc. - Afferent Pharmaceuticals
Merck & Co., Inc. acquires Afferent Pharmaceuticals
Announced: June 09, 2016
Type: Acquisition
Disposition: Combined
Terms: Cash
Status: Complete
Amount: $ 1,250,000,000
Acquisition News
Add News| Date | Title | |
|---|---|---|
| Jun 10, 2016 | Business Wire - Merck to Acquire Afferent Pharmaceuticals |
|
| Jun 09, 2016 | mercknewsroom.com - Merck to Acquire Afferent Pharmaceuticals |
|
Merck & Co., Inc. Other Acquisitions
Add Acquisition| Date | Acquired | Amount |
|---|---|---|
| Oct 10, 2017 |
|
$ 752,000,000 |
| Sep 06, 2017 |
|
Undisclosed amount |
| Jul 11, 2016 |
|
Undisclosed amount |
| Jan 13, 2016 |
|
Undisclosed amount |
| Jul 28, 2015 |
|
$ 95,000,000 |
